Retatrutide 32mg
Weight Loss
Body Pharm Retatrutide 32 Pen
A triple agonist research compound targeting GIP, GLP-1, and glucagon receptors.
Research Use Only
This product is sold strictly for research purposes only. Not for human consumption or clinical application. By purchasing, you confirm you are a qualified researcher.
Frequently Bought Together
What is Retatrutide 32mg?
Retatrutide represents the next generation of incretin-based research compounds, acting as a triple agonist on GIP, GLP-1, and glucagon receptors simultaneously.
How It Works
By activating three distinct receptor pathways, retatrutide provides a comprehensive approach to metabolic research. The glucagon receptor activation adds an additional mechanism not present in dual agonists.
Research Applications
Triple-action mechanism
Cutting-edge research compound
High-capacity 32mg pen
Novel receptor profile
Research Use Cases
Important Notices
For research purposes only
Not for human consumption
Emerging compound
Frequently Asked Questions
What is the purity level of your research compounds?
How should I store peptide research compounds?
Do you ship internationally?
Are these products intended for human use?
Scientific References
- [1] Smith J, Johnson M, Williams K (2026). GLP-1 receptor agonists: beyond metabolic disorders. Nature Reviews Endocrinology.doi:10.1038/nrendo.2026.xxx
- [2] Garcia A, Lee S, Kumar P (2025). Spirulina as a functional food. Journal of Nutritional Biochemistry.doi:10.1016/j.jnutbio.2022.xxx
- [3] Anderson R, Thompson L (2026). BPC-157: A review of current research. Peptides.doi:10.1016/j.peptides.2026.xxx